SEOUL NAT UNIV R & DB FOUND has a total of 12 patent applications. Its first patent ever was published in 2014. It filed its patents most often in WIPO (World Intellectual Property Organization), China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BEIJING ZHIFEI LVZHOU BIOPHARMACEUTICAL CO LTD, MOREDUN RES INST and GENOCEA BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology | |
#5 | Organic fine chemistry | |
#6 | Micro-structure and nano-technology | |
#7 | Civil engineering |
# | Name | Total Patents |
---|---|---|
#1 | Choi Jae Il | 2 |
#2 | Kim Hyo-Soo | 2 |
#3 | Jo Dong Hyun | 2 |
#4 | Kim Jeong Hun | 2 |
#5 | Lee Tae Geol | 2 |
#6 | Hur Jin | 2 |
#7 | Sim Jun | 2 |
#8 | Lee Ho-Young | 2 |
#9 | Nham Pniel | 1 |
#10 | Lee Julian | 1 |
Publication | Filing date | Title |
---|---|---|
WO2017034234A1 | Composite formulation for treating cancer having hdac inhibitor resistance | |
WO2017014601A1 | Indolizino [3,2-c] quinoline-based fluorescent probe | |
WO2016167605A2 | Method for inhibiting lung cancer of smokers and non-smokers using hypertension medicine |